Company profile

Ticker
CLVS
Exchange
CEO
Patrick J. Mahaffy
Employees
Incorporated in
Location
Fiscal year end
SEC CIK
IRS number
900475355

CLVS stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

7 Nov 19
9 Dec 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 37.6M 32.98M 33.12M 30.35M
Net income -94.08M -120.43M -86.42M -99.26M
Diluted EPS -1.72 -2.27 -1.63 -1.88
Net profit margin -250% -365% -261% -327%
Operating income -106.43M -93.46M -85.2M -96.97M
Net change in cash 92.87M -14.7M -98.57M -68.98M
Cash on hand 201.48M 108.61M 123.31M 221.88M
Cost of revenue
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 95.39M 55.51M 78K 0
Net income -368.01M -346.4M -349.14M -352.86M
Diluted EPS -7.07 -7.36 -9.07 -9.79
Net profit margin -386% -624% -447612%
Operating income -333.81M -237.63M -372.73M -376.72M
Net change in cash -242.32M 248.01M -62.57M -203.92M
Cash on hand 221.88M 464.2M 216.19M 278.76M
Cost of revenue 70K 0

Financial data from company earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: agent, aminotransferase, antitumor, array, aspartate, ATM, attach, attachment, average, bind, body, Chancellor, clearance, colorectal, crossfire, DDR, deliver, derecognized, diarrhea, diligent, dismissed, diverse, durable, duty, emerging, endpoint, England, expressed, expression, external, extinguishment, FANCA, FAP, GmbH, imaging, inclusive, independent, injection, irradiated, Israel, Joseph, malignant, Memorandum, mesothelioma, microenvironment, NaN, negotiate, negotiated, negotiating, pancreatic, peptide, percent, persist, platform, preclinical, prevalent, proceed, protein, proximity, PTRT, radiation, radioactive, radiographic, radiological, radionuclide, radiopharmaceutical, rapid, rapidly, RECIST, reinstated, reopen, ruling, Russia, safe, sarcoma, sparing, stroma, suitable, territory, therapeutic, tissue, transient, Turkey, undisclosed, vicinity, vomiting, weighted, whichever, wide
Removed: Additionally, asserting, certificate, committed, committee, commonly, compensatory, correct, County, defend, defense, Del, Domestic, dosage, dosing, driven, efficacy, EGFR, enrolled, epidermal, exclusivity, extension, false, FGFR, forward, inspection, Japan, law, mCRPC, metastatic, move, original, polymorphic, preliminary, protection, punitive, purporting, ranging, receptor, recessionary, rely, Restoration, robust, salt, served, Servier, strength, sublicensed, supplementary, Supreme, vigorously